Immune and Inflammatory Cells in Thyroid Cancer Microenvironment

Area of Science:

• Oncology
• Immunology
• Cancer Research

Background:

• Cancer cells possess the ability to evade immune destruction, a key hallmark of cancer.
• The tumor microenvironment (TME) plays a critical role in cancer progression, involving complex interactions between immune cells, cancer cells, fibroblasts, and endothelial cells.
• Inflammation within the TME, driven by cytokines and chemokines, can promote tumor cell proliferation and immune evasion.

Purpose of the Study:

• To explore the intricate relationship between the tumor microenvironment (TME) and immune responses in cancer.
• To highlight the role of inflammation, cytokines, and chemokines in tumor initiation and progression.
• To emphasize the potential of targeting TME and inflammation for novel diagnostic and therapeutic strategies in advanced thyroid cancer.

Main Methods:

• Review of existing literature on tumor microenvironment (TME) components and their interactions.
• Analysis of the molecular patterns of cytokines and chemokines in the TME.
• Discussion of current and emerging immunotherapeutic strategies, including immune checkpoint inhibitors.

Main Results:

• Tumors employ various mechanisms to impair host immune cells within the TME, including recruitment of immunosuppressive cells and decreased tumor immunogenicity.
• Cytokines and chemokines within the TME are crucial in mediating immune cell interactions and influencing tumor initiation and progression.
• Thyroid cancer-related inflammation presents a significant target for improved diagnostic and therapeutic interventions.

Conclusions:

• A comprehensive understanding of the molecular and immunological landscape of the TME is essential for developing effective cancer therapies.
• Immunotherapy, particularly immune checkpoint inhibitors, shows promise by reactivating cytotoxic lymphocytes against cancer cells.
• Targeting TME-driven inflammation offers a promising avenue for novel and more effective immunotherapeutic strategies in advanced thyroid cancer.